slides · global inventory
Other
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 19,048
Current window 7,291-7,320
Pages 635
Rows per page 30
Slide type
7,291-7,320 of 19,048
44
The slide uses heatmaps to show genetic associations (signed log(p)) for CTLA4 and CD96/CD226 pathways.23andMe | Investor Day Presentation Deck | 78 slides · 23andMe
Conference presentation Investor relations 1 hit
45
The slide uses a biological interaction map to explain the rationale for combination therapy.23andMe | Investor Day Presentation Deck | 78 slides · 23andMe
Conference presentation Investor relations 1 hit
46
The chart shows tumor volume over time for various monotherapy and combination therapy groups, highlighting the triple combination's efficacy.23andMe | Investor Day Presentation Deck | 78 slides · 23andMe
Conference presentation Investor relations 1 hit
47
Includes a process flow diagram for study arms and a table for endpoints.23andMe | Investor Day Presentation Deck | 78 slides · 23andMe
Conference presentation Investor relations 1 hit
52
The slide presents a collection of survival curves and hazard ratio plots from various clinical trials and academic publications.23andMe | Investor Day Presentation Deck | 78 slides · 23andMe
Conference presentation Investor relations 1 hit
61
The slide uses a circular process flow to represent a self-reinforcing business model.23andMe | Investor Day Presentation Deck | 78 slides · 23andMe
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
63
Includes a Manhattan plot and a zoomed-in regional association plot.23andMe | Investor Day Presentation Deck | 78 slides · 23andMe
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
64
The slide uses a linear process flow to explain the methodology behind polygenic risk scoring.23andMe | Investor Day Presentation Deck | 78 slides · 23andMe
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
65
The chart illustrates the predictive validity of polygenic risk scores for BMI.23andMe | Investor Day Presentation Deck | 78 slides · 23andMe
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
04
The slide uses a grid layout to present three distinct case studies of energy storage applications.ads-tec Energy | Investor Presentation Deck | 18 slides · ADS-TEC Energy
Deck Investor relations 1 hit
05
ads-tec Energy | Investor Presentation Deck | 18 slidesads-tec Energy | Investor Presentation Deck | 18 slides · ADS-TEC Energy
Deck Investor relations 1 hit
08
The slide uses a process flow diagram to show energy transformation.ads-tec Energy | Investor Presentation Deck | 18 slides · ADS-TEC Energy
Deck Investor relations Beat · Agitation1 hit
15
The slide uses a split-layout to compare two distinct manufacturing sites.ads-tec Energy | Investor Presentation Deck | 18 slides · ADS-TEC Energy
Deck Investor relations 1 hit
16
The slide displays three distinct real-world deployment examples with location and client context.ads-tec Energy | Investor Presentation Deck | 18 slides · ADS-TEC Energy
Deck Investor relations 1 hit
05
The slide emphasizes global R&D footprint and intellectual property output.AgroFresh | Investor Conference Presentation Deck | 19 slides · AgroFresh
Conference presentation Investor relations 1 hit
07
The slide serves as a portfolio overview of the company's key commercial assets.Alkermes | Investor Conference Presentation Deck | 36 slides · Alkermes
Conference presentation Investor relations Beat · Problem1 hit
16
Alkermes | Investor Conference Presentation Deck | 36 slidesAlkermes | Investor Conference Presentation Deck | 36 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
19
The slide acts as a portfolio overview of the company's primary commercial assets.Alkermes | Investor Conference Presentation Deck | 36 slides · Alkermes
Conference presentation Investor relations Beat · Product1 hit
20
Alkermes | Investor Conference Presentation Deck | 36 slidesAlkermes | Investor Conference Presentation Deck | 36 slides · Alkermes
Conference presentation Investor relations Beat · Product1 hit
29
The slide uses a matrix-like layout to organize clinical trials (ARTISTRY series) by their strategic purpose (Registration, Dose, Collaboration).Alkermes | Investor Conference Presentation Deck | 36 slides · Alkermes
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
Anghami | SPAC Presentation Deck | 29 slidesAnghami | SPAC Presentation Deck | 29 slides · Anghami
Pitch deck Investment bank Loop · Day In Life1 hit
18
The slide uses a hub-spoke style diagram to show the 50/50 ownership structure.Anghami | SPAC Presentation Deck | 29 slides · Anghami
Pitch deck Investment bank Loop · Day In Life1 hit
06
The diagram uses a circular flow representing 'Ignore axis' and 'Defend axis' strategies in cancer treatment.AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
18
The slide uses a standard clinical trial flow diagram (CONSORT-style).AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
20
Clinical trial data visualization (Kaplan-Meier plot).AstraZeneca | Investor Day Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
23
The slide uses a process flow to map research/clinical stages to specific de-risking milestones.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
25
The slide includes a time-series line chart showing fEPSP slope over time and a bar chart showing fEPSP amplitude changes across different treatment conditions.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
33
The slide outlines a clinical trial design including screening, in-patient dosing, and follow-up phases.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations 1 hit
36
The slide includes a visual representation of the BACS symbol coding test.ATAI | Investor Day Presentation Deck | 42 slides · atai Life Sciences
Conference presentation Investor relations 1 hit
112
Blackwells Capital | Activist Presentation Deck | 207 slidesBlackwells Capital | Activist Presentation Deck | 207 slides · Blackwells Capital
Activist deck Activist investor 1 hit